Leptin is a hormone secreted by adipocytes in correlation with total body fat mass. In addition to regulating energy homeostasis, leptin modulates immune functions such as macrophage phagocytosis and cytokine synthesis. Previously, we reported defective leukotriene synthesis in macrophages from leptin-deficient mice that could be restored with exogenous leptin. In the present study, we utilized macrophages from normal rodents to explore the mechanism by which leptin could enhance cellular leukotriene synthesis. Leptin pretreatment of either rat alveolar or murine peritoneal macrophages for 16 h dose-dependently increased the synthesis of leukotriene B 4 and cysteinyl-leukotrienes in response to calcium ionophore or the particulate zymosan.
Introduction
The leukotrienes (LTs) are potent lipid mediators of inflammation that play important roles in a variety of inflammatory disease states as well as in host defense against infection (3, 34) . The initial step in the generation of eicosanoids is the liberation of arachidonic acid (AA) and other 20-carbon unsaturated fatty acids from tissue phospholipid pools, which involves the actions of one or more phospholipase A 2 (PLA 2 ) enzymes. The enzyme 5-lipoxygenase (5-LO), in conjunction with 5-LO activating protein (FLAP), can oxygenate AA to form LTA 4 . This intermediate can be hydrolyzed to form the potent neutrophil chemoattractant, LTB 4 , or conjugated with glutathione to form the cysteinyl-LTs (LTC 4 , LTD 4 , and LTE 4 ), which elicit smooth muscle contraction and microvascular permeability (30) . Alternative metabolism of AA via the cyclooxygenase pathway results in the formation of prostaglandins or thromboxane.
Leptin, the 16-kDa protein product of the ob gene, is a pleotropic hormone that is produced primarily by adipocytes. In general, circulating leptin levels are linearly correlated with total body fat mass (23, 41) . However, leptin levels drop rapidly during fasting and increase in response to infection and inflammatory stimuli (1, 33) . In addition to regulating appetite and energy expenditure, leptin is an important immunoregulatory hormone since it enhances a number of immune responses including macrophage effector functions (16, 21) , cytokine synthesis, and Th cell polarization to a Th1 phenotype (22) .
In a previous report, we observed a link between leptin and LT synthesis since we found that LT synthesis was reduced in macrophages from leptin-deficient mice. The defect in LT synthesis could be reversed by pretreating macrophages overnight with exogenous leptin (25) . In addition to this observation, leptin has been reported to enhance cPLA 2 4 activity in bone marrow stromal cells and increase hypothalamic prostaglandin synthesis in rats (9, 19) . In this report, we utilized normal rat alveolar macrophages (AMs) and murine peritoneal macrophages (PMs) to examine the mechanisms by which leptin increases LT synthetic capacity.
Materials and Methods

Isolation and culture of murine PMs and rat AMs.
Resident murine PMs and rat AMs were obtained from specific pathogen-free female C57BL/6j mice (The Jackson Laboratory, Bar Harbor, ME) and female Wistar rats (Charles River, Portage, MI), respectively, by lavage as previously described (31) . After 1 h, the cell culture medium was replaced with complete medium (RPMI containing 10% fetal bovine serum and 1% penicillin/streptomycin) (Gibco), and the macrophages were cultured for 16 h.
Macrophage stimulation and eicosanoid analysis.
Macrophages were cultured with medium alone or with increasing doses of either murine leptin (Calbiochem, San Diego) (for murine PMs), rat leptin peptide (Diagnostic Systems Laboratories, Webster, TX) (rLep) or rat leptin (Sigma, St. Louis, Mo.) (for rat AMs). The following day, the cells were washed with warm PBS and the medium was 6 replaced with RPMI alone or with RPMI containing leptin. The cells were incubated with or without the agonist calcium ionophore A23187 (Calbiochem) at 10 µM for 30 min. In some experiments, the cells were stimulated with the particulate stimulus zymosan (Sigma) at 0.1 mg/ml for 1 h. Medium was collected and stored at -70ºC and was later assayed for LTB 4 , cysteinyl-LTs, and prostaglandin E 2 (PGE 2 ) using commercially available EIA kits (Cayman Chemical, Ann Arbor, MI).
Arachidonic acid release.
Rat AM phospholipids were isotopically labeled by culturing overnight in complete medium including 0. Released AA was evaluated as the total counts recovered in culture medium and expressed as a percentage of incorporated radioactivity.
Phospholipase A 2 activity assay.
Phospholipase A 2 activity was determined in lysates of rat AMs (10 x 10 6 cells/ ml) as previously described (39) . Briefly, cells cultured overnight with and without rLep 
Immunoprecipitation of cPLA 2
Rat AM monolayers were lysed in buffer containing 1% Trition x-100 with 50
mM Tris (pH 8.0), 100 mM NaCl, 1mM Na 3 VO 4 , 1mM PMSF, 50 mM NaF and 1 µg/ml Membranes were then probed with the antibodies to total phosphorylated cPLA 2 as described below.
Immunoblot analysis of 5-LO, FLAP,cPLA 2 , cPLA 2 , and phospho-cPLA 2 Immunoblot analysis of macrophage 5-LO, FLAP, 85-kDa cytosolic PLA 2 (cPLA 2 ), and Group IVC iPLA 2 (cPLA 2 ) was performed as previously described (8) .
Briefly, rat AMs (2 x 10 6 /well) were cultured overnight with complete medium with and 9 without 5 ng/ml of rat leptin. The following day, the macrophages were washed with HBSS, scraped with ice-cold homogenization buffer (50mM Tris-HCl, 25mM KCl, 5mM 
Results
Leptin enhances macrophage leukotriene and PGE 2 synthesis.
To determine if leptin modulates LT synthesis in macrophages, we cultured rat AMs and resident murine PMs overnight with medium alone or with increasing doses of rLep (at the time that these studies were initiated the full length rat leptin protein (16-kDa) was not commercially available) or murine leptin. On the following day, the cells were stimulated to produce LTs with calcium ionophore. In the absence of calcium ionophore, we could not detect LTs in medium from cells treated with or without leptin (data not shown). As shown in Figure 1A , rLep pretreatment increased LTB 4 synthesis in calcium ionophore-stimulated rat AMs. The peak LTB 4 levels (3-fold greater than the control) were produced with a 5 ng/ml dose of rLep. At higher concentrations of rLep (50 and 500 ng/ml), LTB 4 synthesis declined but was still approximately 2.5-fold greater than the control. Similarly, when the full-length leptin protein was commercially available, we repeated the dose response experiment and found that LTB 4 levels peaked with a 5 ng/ml dose of rat leptin, which was in the physiologic range of 1 to 10 ng/ml and 2-fold greater than the control (data not shown). Likewise, using the particulate zymosan, a physiologic stimulus for LT synthesis, rat leptin pretreatment augmented LTB 4 synthesis at the dose of 5 ng/ml (Figure 1 B) . Heat inactivation of leptin by boiling for 30 min completely inhibited the ability of leptin to augment leukotriene synthesis, indicating that leptin, rather than potential endotoxin contamination, was responsible for the enhancement of leukotriene synthesis (data not shown). We also observed that murine leptin pretreatment enhanced resident PM LTB 4 and cysteinyl-LT synthesis in a dose-dependent manner indicating that leptin can enhance leukotriene synthesis in other types of macrophages ( Figure 2 ).
In order to determine if the effects of leptin were confined to the 5-LO pathway, we also measured the levels of the cyclooxygenase product, PGE 2 , in leptin pretreated rat AMs stimulated with zymosan. As shown in Figure 3 , leptin augmented the synthesis of PGE 2 in a dose dependent manner. The synthesis of PGE 2 in response to leptin pretreatment increased by 45% at 5 ng/ml, peaked at 10 ng/ml (although not a significant increase) and declined (25% increase) with the highest dose of 50 ng/ml. While the augmentation of PGE 2 synthesis was less than that observed for LT synthesis, this result suggests that leptin influences a proximal step in the eicosanoid synthetic pathway that is common to both oxygenate pathways.
Leptin enhances macrophage arachidonic acid release.
Accordingly, we next assessed the ability of rLep to modulate substrate AA release in rat AMs. rLep did not significantly affect the uptake of [ 3 H] AA (data not shown). As shown in Figure 4 , overnight rLep pretreatment augmented calcium ionophore-stimulated rat AM AA release in a dose-dependent manner. The maximal effect, a doubling of the control level of release, was observed at physiologic levels of rLep (5 ng/ml) and declined at higher levels (50 and 500 ng/ml).
Leptin enhances PLA 2 activity in rat AM lysates.
To determine if the increase in AA release with leptin pretreatment reflected increased activity of the enzyme(s) responsible for deacylation, we performed cell-free 13 PLA 2 assays in rat AMs. At baseline, PLA 2 activity against both of the phospholipid substrates, 14 C-AA-PC ( Figure 5A ) and 14 C-LA-PC ( Figure 5B ), was observed in both the presence and absence of calcium. However, PLA 2 activity increased significantly with rLep (5 ng/ml) pretreatment only when 14 C-AA-PC was used as the substrate. Both calcium-dependent and calcium-independent PLA 2 activities were enhanced by rLep, by approximately 50 and 90%, respectively.
Effect of leptin on LT biosynthetic proteins.
We explored the possibility that some of the effects of leptin could be mediated by increases in the levels of the key regulatory enzymes in the LT synthetic pathway.
We evaluated 5-LO, FLAP, cPLA 2 , and cPLA 2 protein expression by immunoblot analysis in rat AMs following overnight pretreatment with rat leptin (5 ng/ml). 
Discussion
Previously, we observed that cysteinyl-LT synthesis in macrophages from leptindeficient mice was impaired and that in vitro addition of exogenous leptin was able to restore cysteinyl-LT synthesis in PMs from these mice (25) . In this study, we explored the mechanism by which leptin modulates LT synthesis in macrophages from normal mice and rats. We found that leptin pretreatment enhanced both LTB 4 (rat AMs and murine PMs) and cysteinyl-LT (murine PMs) synthesis in a dose dependent manner.
Taken together, these experiments demonstrate that the ability of leptin to increase LT synthesis extends to a variety of macrophage populations, AMs and PMs, rat and mouse, and stimulated with both soluble (A23187) and particulate (zymosan) stimuli. These findings are pathophysiologically relevant since we have already shown that murine leptin levels rise to approximately 10 ng/ml in the lungs and 7 ng/ml in blood in the setting of gram-negative pneumonia (25) . Others have also observed increases in leptin in response to inflammatory stimuli in both rodents and humans (5-7, 17, 27, 28) . Since
LTs have been shown to play an important role in host defense against K. pneumonia by augmenting phagocytosis and microbial killing (3, 26) , the ability of leptin to increase LT synthesis by macrophages would be expected to contribute to its homeostatic role in antimicrobial host defense.
We noted that LTB 4 synthesis in murine PMs increased nearly 5-fold at the highest dose of leptin, while the maximal increase of cysteinyl-LT synthesis was only 2.5 -fold. This increase was greater than what would have been predicted if the effect of leptin was limited to enhanced AA release. While we did not observe changes in 5-LO or FLAP expression with a 5 ng/ml dose of leptin in rat AMs, we cannot rule out the possibility that higher concentrations of leptin might enhance the expression of these and other proteins that regulate the LT biosynthetic pathway. It also raises the possibility that leptin may also be capable of augmenting the activity and or expression of LTA 4 hydrolase, the enzyme that converts LTA 4 to LTB 4 in macrophages (30) . Future studies will be necessary to resolve these possibilities.
To determine if the effect of leptin on eicosanoid synthesis was specific for LTs, we measured PGE 2 , a cyclooxygenase product produced by AMs in response to zymosan.
This response increased by 45% when the PMs were pretreated with leptin (5 ng/ml).
Interestingly, Brunetti and colleagues found that exogenous leptin enhanced the synthesis of the cyclooxygenase products PGE 2 and PGF 2 in rat hypothalamic cells (9) . While the effect of leptin on PGE 2 was much less than that observed for LTs, it suggests that leptin can augment a proximal step in eicosanoid biosynthesis common to both cyclooxygenase and 5-LO pathways.
Since AA release is necessary for the synthesis of both PGE 2 and LTs, we examined this step in both intact cell and cell-free assays. We observed that leptin enhanced AA release from rat AMs in a dose-dependent manner. The effect of leptin on AA release in intact cells was confirmed by the observation that leptin enhanced cell-free PLA 2 activity in macrophage lysates. In particular, leptin enhanced PLA 2 activity assayed under both calcium-dependent and calcium-independent conditions, but only when 14 C-AA-PC, and not 14 C-LA-PC, was the substrate. This finding suggests that leptin can enhance the enzymatic activity of an arachidonoyl-preferring PLA 2 .
It is well established that multiple isoforms of PLA 2 Calcium is an essential co-factor for the liberation of AA by cPLA 2 from cell membrane phospholipids and the subsequent conversion of AA to LTs by the enzyme 5-LO. We observed an enhancement of PLA 2 activity both in the presence and absence of calcium. This suggests that leptin enhances the activity of a PLA 2 enzyme that can function with and without calcium. We demonstrate for the first time that rat AMs express cPLA 2 , an arachidonoyl-prefering calcium-independent enzyme, and this may have contributed to the AA-specific calcium-independent activity. This enzyme is capable of liberating AA in both the presence and absence of calcium (32) . Interestingly, leptin increased the expression of this enzyme by approximately 80%, and this may have contributed to the increase in AA released in intact macrophages following leptin pretreatment. This is also the first report, to our knowledge, of a mediator that is capable of increasing the expression of cPLA 2 . Although the activation of calcium-independent PLA 2 isoforms has been implicated in constitutive phospholipid remodeling (2), agoniststimulated AA release by calcium-independent PLA 2 activity has also been linked to eicosanoid synthesis (4, 29, 32, 38) .
Our data suggest previously unrecognized mechanisms by which leptin can promote inflammatory responses. These findings may be relevant to human diseases in which eicosanoids play a pathophysiologic role. For example, recent epidemiological studies have shown an association between asthma and obesity in adults (10, 12) . In addition, leptin has been implicated as an important mediator of osteoarthritis (14) . It is possible that the increased incidence of asthma and osteoarthritis associated with obesity, a circumstance characterized by the overproduction of leptin, is related to the ability of leptin to augment LT and PGE 2 synthesis, respectively. However, obese individuals exhibit leptin resistance and our results may be an overestimate of the ability of leptin to augment LT synthesis in the obese (15) . In contrast to obesity, malnutrition is a common primary problem and also a secondary consequence of many disease states, such as HIV infection, emphysema, and cancer. By virtue of reduced LT synthetic capacity observed in many of these conditions, leptin deficiency may contribute to impaired host defense against infection (11, 18, 36) . Our present results provide a rationale for future studies exploring leptin's effects on AA release and cPLA 2 in such pathophysiologic states. 
